✦ LIBER ✦

Imaging and cerebrospinal fluid biomarker results of a phase II dose-ranging study of ELND005 (Scyllo-inositol) in mild-to-moderate Alzheimer's disease

✍ Scribed by Porsteinsson, Anton; Sperling, Reisa; Salloway, Stephen; Keren, Ron; van Dyck, Christopher; Tariot, Pierre; Arnold, Douglas; Crans, Gerald; Hernandez, Ramon; Liang, Earvin; Bairu, Menghis; Cedarbaum, Jesse; Pastrak, Aleksandra; Abushakra, Susan

Book ID: 123310329
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 56 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.2010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy results of a phase I

Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's disease

✍ Salloway, Stephen; Porsteinsson, Anton; Sperling, Reisa; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Effects of oral ELND005 (Scyllo-inositol

Effects of oral ELND005 (Scyllo-inositol) on brain scyllo-inositol and myo-inositol levels: Spectroscopy results from a phase 2 study in MILD-TO-MODERATE Alzheimer's disease

✍ Liang, Earvin; Tariot, Pierre; Abushakra, Susan; Porsteinsson, Anton; Hernandez, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Effects of oral ELND005 (scyllo-inositol

Effects of oral ELND005 (scyllo-inositol) on neuropsychiatric symptoms in a 78-week phase 2 study in mild/moderate Alzheimer's disease (AD): Potential role of myo-inositol reduction

✍ Lyketsos, Constantine; Abushakra, Susan; Liang, Earvin; Hernandez, Ramon; Tariot 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Safety and tolerability of BMS-708163 in

Safety and tolerability of BMS-708163 in a phase II study in mild-to-moderate Alzheimer's disease

✍ Salloway, Stephen; Coric, Vlad; Brody, Mark; Andreasen, Niels; van Dyck, Christo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 82 KB

A multicenter, double-blind, placebo-con

A multicenter, double-blind, placebo-controlled phase IIb proof-of-concept dose-ranging study of AZD3480 and donepezil over 12 weeks in patients with mild to moderate Alzheimer's disease

✍ Lutz Frölich; Göran Eckerwall; Nilsson Jonas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Safety and efficacy of AN2728 topical oi

Safety and efficacy of AN2728 topical ointment, 2% and 0.5%, in a phase II dose-ranging study of adolescents with mild to moderate atopic dermatitis

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 44 KB